Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study

Hongjie Cai,1 Song Chen,2 Zhiqiang Wu,1 Fan Wang,1 Shuangyan Tang,1 Ludan Chen,1 Wenbo Guo1 1Department of Interventional Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510062, People’s Republic of China; 2Department of Minimally Invasive Interventional Therapy, Sun Y...

Full description

Bibliographic Details
Main Authors: Cai H, Chen S, Wu Z, Wang F, Tang S, Chen L, Guo W
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
immune checkpoint inhibitors
tyrosine kine inhibitors
local therapy
systemic therapy
large unresectable hepatocellular carcinoma.
Online Access:https://www.dovepress.com/atezolizumab-plus-bevacizumab-combined-with-transarterial-embolization-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/atezolizumab-plus-bevacizumab-combined-with-transarterial-embolization-peer-reviewed-fulltext-article-JHC

Similar Items